|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.61 CNY | +1.14% |
|
+0.22% | +5.62% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 24.7 | +34.24% | 7 | ||||||
| 60.65 | +89.84% | 16 | ||||||
| 2,976 | +21.05% | 10 | ||||||
| 33.22 | +52.5% | 12 | ||||||
| 124.21 | +33.55% | 9 | ||||||
| 327.88 | +54.46% | 8 | ||||||
| - | - | 1,415 | +195.37% | 1 | ||||
| 47 | +16.19% | 6 | ||||||
| 84.2 | +27.48% | 10 | ||||||
| 37.19 | +25.42% | 8 | ||||||
| 14.86 | +35.73% | 5 | ||||||
| 54.32 | +33.81% | 8 | ||||||
| 1,013.14 | +40.61% | 7 | ||||||
| - | 92.5 | +27.94% | 2 | |||||
| - | 5,100 | +34.92% | 2 | |||||
| 10.22 | -1.36% | 8 | ||||||
| Average | 713.44 | +45.11% | 7 | ||||||
| Weighted average by Cap. | 608.95 | +60.12% | 10 |
Select your edition
All financial news and data tailored to specific country editions
